Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-04

Clinical Trial Update: The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes [NA]

View source ↗

Summary

This document is a clinical trial update describing the study of pyridoxamine supplementation and its effects on microvascular function in individuals with Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyridoxamine (pyridoxamine)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Type 2 Diabetes, Microvascular Function | NA | Status: ACTIVE_NOT_RECRUITING